Open AccessBlood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
Author(s) -
Harald Hampel,
Andrea Vergallo,
Mohammad Afshar,
Leyla Akman-Anderson,
Joaquín Arenas,
Norbert Benda,
Richard Batrla,
Karl Broich,
Filippo Caraci,
A. Claudio Cuello,
Enzo Emanuele,
Marion Haberkamp,
Steven J. Kiddle,
Alejandro Lucía,
Mark Mapstone,
Steven R. Verdooner,
Janet Woodcock,
Simone Lista
Publication year - 2019
Publication title -
dialogues in clinical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.11
H-Index - 87
eISSN - 1958-5969
pISSN - 1294-8322
DOI - 10.31887/dcns.2019.21.2/hhampel
Subject(s) - disease , decipher , druggability , clinical trial , biomarker , mechanism (biology) , drug trial , systems biology , epigenetics , bioinformatics , drug development , medicine , alzheimer's disease , drug , computational biology , biology , pharmacology , pathology , genetics , philosophy , epistemology , gene